NUVB FY 2025 Earnings — Nuvation Bio Inc. Revenue & Financial Results | Market Cap Arena

NUVBNuvation Bio Inc.

$2B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$63M+699.0% YoY

Gross Profit

$54M86.6% margin

Operating Income

-$213M-338.7% margin

Net Income

-$205M-325.3% margin

EPS (Diluted)

$-0.60

Cash Flow

Operating Cash Flow

-$173M

Free Cash Flow

-$174M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$595M

Total Liabilities

$289M

Stockholders' Equity

$306M

Cash & Equivalents

$164M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$63M	$8M	+699.0%
Gross Profit	$54M	$795,000	+6750.3%
Operating Income	-$213M	-$593M	+64.0%
Net Income	-$205M	-$568M	+64.0%